Archives
-
Reversine: Aurora Kinase Inhibitor for Mitotic Research
2026-08-25
Reversine is an Aurora kinase inhibitor used to investigate mitotic regulation, cancer cell proliferation inhibition, and apoptosis induction in cancer cells. Product data report activity against Aurora kinases A, B, and C, while peer-reviewed work supports its use in cell-fate and high-content cellular research.
-
Dicloxacillin Activity Against Intracellular S. aureus
2026-08-24
The reference study compared dicloxacillin activity against intracellular and extracellular Staphylococcus aureus using THP-1 cells and a modified mouse peritonitis model. Its central finding was that free-drug exposure above the MIC, rather than peak concentration or total exposure alone, best predicted efficacy in both compartments, providing a useful PK/PD framework for MSSA infection research.
-
JNJ-26854165 (Serdemetan) Assay Workflows
2026-08-24
Build more informative HDM2–p53 experiments with JNJ-26854165 (Serdemetan), separating growth arrest from true cell killing. This workflow also supports genotype-aware apoptosis studies, migration assays, and radiation-response experiments rather than relying on a single viability endpoint.
-
L1023 Anti-Cancer Compound Library Workflow
2026-08-23
Turn a 1,164-compound collection into a practical discovery engine for pathway profiling, phenotypic screening, and mechanism-focused cancer research. This workflow pairs broad chemical coverage with orthogonal validation strategies inspired by the DHHC9–STRN4–YAP metastasis study.
-
Y-27632 in NIID iPSC Assay Design
2026-08-22
Explore how Y-27632, a selective ROCK inhibitor, can be used as a mechanistic perturbation tool in patient-derived NIID iPSC research. This article connects ROCK-dependent cytoskeletal phenotypes with the NOTCH2NLC repeat-expansion model while defining practical assay limits.
-
SIS3 Smad3 Inhibitor: Practical Research Workflows
2026-08-22
SIS3 provides a selective way to interrogate Smad3-dependent TGF-β signaling without treating Smad2 as an equivalent readout. This guide translates that selectivity into reproducible workflows for fibrosis research, renal fibrosis models, diabetic nephropathy research, and mechanistic studies of lung adenocarcinoma.
-
Triamcinolone (B1859): Practical Research Workflow
2026-08-21
Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide covers solvent selection, stock preparation, storage, assay controls, and troubleshooting; the material is for scientific research only and not for diagnostic, therapeutic, or clinical use.
-
HyperScript™ Reverse Transcriptase for RNA-to-cDNA
2026-08-20
HyperScript™ Reverse Transcriptase is designed for demanding RNA to cDNA conversion, including structured transcripts, long targets, and low-abundance RNA. This practical guide connects enzyme selection with qPCR assay design, workflow controls, and troubleshooting for more reliable molecular measurements.
-
Dye Models for Small Tissue Biopsies in Pathology
2026-08-20
This 2023 study evaluated five dyes as pre-processing markers for improving the visibility of 0.2–0.3 cm biopsy fragments during routine pathology workflows. Merbromin, hematoxylin, and Alcian blue improved visual detection, but hematoxylin provided the most favorable balance of visibility, lower toxicity, and minimal interference with diagnostic slide examination.
-
Lipidated Nanophotosensitizers Disable Tumor EVs
2026-08-19
The reference study developed palmitic-acid-displayed nanoparticles that trace tumor extracellular vesicles (TEVs) and deliver reactive oxygen species both inside tumor cells and within TEVs. In female mouse tumor models, this dual localization combined suppression of primary tumor growth with disruption of TEV-mediated communication linked to metastasis.
-
2,2,2-Trichloroethanol for Protein Analysis
2026-08-19
2,2,2-Trichloroethanol provides a practical in-gel protein analysis route that complements imaging-led neuroscience workflows. Its solvent compatibility and flexible use as a small molecule biochemical support reproducible molecular biology research, while careful controls help distinguish protein-quality signals from biological conclusions.
-
FXR Phase Separation Organizes Coronavirus Replication
2026-08-18
Li et al. show that fragile X–related proteins organize β-coronavirus replication organelles by liquid–liquid phase separation, clustering double-membrane vesicles and concentrating viral and translational components. The work connects condensate biology with membrane remodeling and identifies FXR-dependent DMV organization as a measurable determinant of SARS-CoV-2 replication.
-
VE-822 ATR Inhibitor: Practical Assay Workflows
2026-08-18
VE-822 is a potent ATR inhibitor for testing replication-stress biology, DNA damage response inhibition, and tumor-selective radiosensitization. This workflow-centered guide shows how to move from controlled 2D assays to ECM-supported 3D models while avoiding solubility, timing, and analysis errors.
-
PDGF-BB for Mechanistic PH Assay Design
2026-08-17
PDGF-BB enables a calibration-first approach to pulmonary hypertension research. This guide shows how murine recombinant PDGF-BB can separate receptor-driven smooth muscle cell proliferation from hypoxia-associated lactate and mitochondrial mechanisms.
-
TUNEL Evidence for Bone-Protection Research
2026-08-17
A translational framework for using TUNEL fluorescence to connect PTX3–TLR4/NF-κB/FGF21 biology with measurable apoptosis in osteonecrosis models, while choosing practical readouts for tissue sections and cultured cells.